Literature DB >> 8446550

The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients.

B Rudensky1, S Rosner, M Sonnenblick, Y van Dijk, E Shapira, M Isaacsohn.   

Abstract

Rectal swabs obtained from 10 of 49 chronic-care geriatric patients were positive for Clostridium difficile, for a prevalence rate of 20.4%. Simultaneous sampling of 29 patients in an acute geriatric ward revealed four colonized patients, for a prevalence rate of 13.7%. A prospective study of C. difficile colonization in 100 consecutive patients admitted to an acute geriatric ward was carried out. All patients were sampled upon admission and biweekly during hospitalization. Two patients (2%) were positive on admission, and 12 of the 98 initially negative patients became colonized, representing a nosocomial acquisition rate of 12.2%. A major determinant for C. difficile colonization in asymptomatic patients appears to be length of hospitalization. Previous antibiotic administration was not found to be a significant factor.

Entities:  

Mesh:

Year:  1993        PMID: 8446550      PMCID: PMC2399593          DOI: 10.1136/pgmj.69.807.45

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  Clostridium difficile in the elderly.

Authors:  S P Borriello; F E Barclay
Journal:  J Infect       Date:  1991-05       Impact factor: 6.072

2.  Rectal swab cultures for Clostridium difficile surveillance studies.

Authors:  L V McFarland; M B Coyle; W H Kremer; W E Stamm
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

3.  Is Clostridium difficile endemic in chronic-care facilities?

Authors:  B S Bender; R Bennett; B E Laughon; W B Greenough; C Gaydos; S D Sears; M S Forman; J G Bartlett
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

4.  Clostridium difficile diarrhoea: a highly infectious organism.

Authors:  G C Bennett; E Allen; P H Millard
Journal:  Age Ageing       Date:  1984-11       Impact factor: 10.668

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Clostridium difficile in acute and long-stay elderly patients.

Authors:  R R Campbell; D Beere; G K Wilcock; E M Brown
Journal:  Age Ageing       Date:  1988-09       Impact factor: 10.668

7.  Comparison of Minitek Anaerobe II, API An-Ident, and RapID ANA systems for identification of Clostridium difficile.

Authors:  G Bate
Journal:  Am J Clin Pathol       Date:  1986-06       Impact factor: 2.493

8.  Postantibiotic colonization with Clostridium difficile in nursing home patients.

Authors:  D R Thomas; R G Bennett; B E Laughon; W B Greenough; J G Bartlett
Journal:  J Am Geriatr Soc       Date:  1990-04       Impact factor: 5.562

9.  Acquisition of Clostridium difficile from the hospital environment.

Authors:  G W Kaatz; S D Gitlin; D R Schaberg; K H Wilson; C A Kauffman; S M Seo; R Fekety
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

10.  Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks.

Authors:  R G Bennett; B E Laughon; L M Mundy; L D Bobo; C A Gaydos; W B Greenough; J G Bartlett
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

View more
  12 in total

1.  Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency.

Authors:  J H Boone; M Goodykoontz; S J Rhodes; K Price; J Smith; K N Gearhart; R J Carman; T M Kerkering; T D Wilkins; D M Lyerly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

Review 2.  Clostridium difficile in the ICU: the struggle continues.

Authors:  Linda D Bobo; Erik R Dubberke; Marin Kollef
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

Review 3.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

5.  Clostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in Turkey.

Authors:  G Söyletir; A Eskitürk; G Kiliç; V Korten; N Tözün
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

6.  Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.

Authors:  Erik R Dubberke; Kimberly A Reske; Sondra Seiler; Tiffany Hink; Jennie H Kwon; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

Review 7.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

8.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

9.  Impact of toxigenic Clostridium difficile colonization and infection among hospitalized adults at a district hospital in southern Taiwan.

Authors:  Yuan-Pin Hung; Pei-Jane Tsai; Kuei-Hsiang Hung; Hsiu-Chuan Liu; Chih-I Lee; Hsiao-Ju Lin; Yi-Hui Wu; Jiunn-Jong Wu; Wen-Chien Ko
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

10.  Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients.

Authors:  Stojanovic Predrag; Kocic Branislava; Stojanovic Miodrag; Miljkovic-Selimovic Biljana; Tasic Suzana; Miladinovic-Tasic Natasa; Babic Tatjana
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.